Transcriptomic drug-response gene signatures are informative for the stratification of patients for clinical trials

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 149; no. 1; pp. 55 - 57
Main Authors Foster, Paul S., Barnes, Jessica L., Tay, Hock L., Gibson, Peter G.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.01.2022
Subjects
Antibodies, Monoclonal, Humanized - therapeutic use
asthma subtypes
Atopic dermatitis
Dermatitis, Atopic - drug therapy
fezakinumab
Humans
IL-22
Pharmaceutical Preparations
TH22
Transcriptome
transcriptomics
asthma subtypes
transcriptomics
TH22
Atopic dermatitis
IL-22
fezakinumab
T(H)22
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ObjectType-Article-3
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2021.09.021